Low-dose naltrexone – a research blog for patients and caregivers
Welcome to our research blog on Low-dose naltrexone. We are using this blog to explore both the experience of people who have used the medication but also barriers to accessing the medication.
Over the course of the last few years there has been an increasing about of discussion regarding the use of Low-dose naltrexone (LDN) to treat various medical conditions such as multiple sclerosis, Crohn’s disease and fibromyalgia. Recent research from the University of Freiburg has indicated that LDN may also be useful in treating disassociation which can be associated with borderline personality disorders and posttraumatic stress disorder (PTSD).
LDN is a controversial product not least because it was developed as a way of treating heroin addiction. For MS, for example, the jury is still out on its effectiveness. But that does not stop many patients advocating its use! That is why we are very interested in the opinions of people who have used LDN.
We are particularly interested in the following questions:-
a) Have you ever used LDN and for what condition was it prescribed?
b) How effective was LDN for treating your condition?
c) How easy was it for you to be prescribed LDN? Were you ever turned down for it?
d) How did you find out about LDN?
e) What sources of information would you recommend to others regarding LDN?
f) Did you ever consider using LDN which had not been prescribed by a physician?
Please do treat these questions as a guide we would love to have any comments you might make!
To take part in the research blog please simply go down to the bottom of the page and add you comments in the box provided. Alternatively you can reply to the comments and experiences of others.
Thanks very much!
Follow us on Twitter:
Follow @Patientsvoice
We run a number of research project with people with all types of medical conditions each year and if you would be interested in taking part in these kinds of projects or any other medical or healthcare market research why not join us at The Patients Voice by clicking the button below.
If you have any comments to make about this article please use the comment box provided below.
